Cosmax (A192820) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
12 Aug, 2025Executive summary
Achieved record high revenue of KRW 623.6 bn (+13.1% YoY) and operating profit of KRW 60.8 bn (+30.2% YoY), driven by global expansion and regional strategies.
Net profit declined 38.1% YoY to KRW 21.8 bn due to increased non-operating expenses, including interest and FX losses.
Korea led growth with strong exports and K-beauty demand, while Southeast Asia also posted robust gains; US and China showed mixed results.
Financial highlights
Revenue rose 13.1% YoY to KRW 623.6 bn; operating profit up 30.2% YoY to KRW 60.8 bn.
Gross profit increased slightly by 0.7% YoY to KRW 112.9 bn; SG&A expenses fell 20.3% YoY.
Net profit dropped 38.1% YoY to KRW 21.8 bn, mainly due to higher non-operating losses.
Cost of sales ratio at 81.9%, SG&A ratio at 8.3%, and operating margin at 9.8%.
Outlook and guidance
US revenue expected to recover in 2H 2025 by focusing on high-growth categories like suncare and body care.
Continued emphasis on global market expansion and tailored regional strategies.
Latest events from Cosmax
- Strong revenue and profit growth in 4Q 2025, led by health supplement and holding segments.A192820
Q4 20258 Mar 2026 - Korea and Southeast Asia drove robust profit growth, offsetting China and US weakness.A192820
Q3 202420 Feb 2026 - Q2 2024 delivered double-digit sales and profit growth, driven by Korea and Southeast Asia.A192820
Q2 202420 Feb 2026 - Record Q4 profit growth driven by Korea and Southeast Asia, with net profit turning positive.A192820
Q4 202420 Feb 2026 - Revenue and operating profit grew, but net profit dropped due to one-off and non-operating losses.A192820
Q1 202520 Feb 2026 - Revenue up 1.0% YoY, but net loss widened on one-off costs; BTI outperformed.A192820
Q3 202520 Feb 2026